PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment
Clinical trial NCT04634058 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04634058
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-26
- Primary completion
- 2023-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.